Introduction: -
The multimodal imaging market refers to the market
for medical imaging systems that are capable of combining two or more imaging
modalities, such as magnetic resonance imaging (MRI), computed tomography (CT),
positron emission tomography (PET), and single photon emission computed
tomography (SPECT), to provide a more comprehensive and accurate view of the
human body.
Global
multimodal imaging market Overview
The report Multimodal
Imaging Market is projected to reach USD 2.9
billion by 2024 from USD 2.3 billion in 2019, at a CAGR of 4.4%
Growing applications of multimodal imaging systems,
technological advancements in diagnostic imaging modalities, availability of
funding for research, favorable reimbursement scenario, growing insurance
coverage, and increasing R&D into radiotracers are some of the key factors
driving the multimodal imaging market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3358876
Market Segmentation: -
The
PET/CT segment accounted for the largest share of the multimodal imaging
market, by technology, in 2018
Based on technology, the multimodal imaging market
is broadly segmented into PET/CT systems, PET/MR systems, SPECT/CT systems,
OCT/Fundus Imaging systems, and other multimodal imaging systems (tri-modality
systems such as SPECT/CT/PET, PET/CT + MR, and IVUS + NIRS systems, among
others).
The PET/CT systems segment accounted for the largest
share of the multimodal imaging market in 2018. This can be attributed to the
increasing demand for early and accurate cancer diagnosis, growing clinical
evidence for the early detection of Alzheimer’s disease, increasing
applications of PET/CT systems in cardiology, favorable reimbursement scenario,
and the technological advancements in the field of PET/CT.
The
oncology segment registered the highest CAGR in the multimodal imaging market
in 2018
On the basis of application, the multimodal imaging
market is segmented into brain & neurology, cardiology, oncology,
ophthalmology, and other applications. The oncology segment registered the
highest CAGR in 2018. This can be attributed to the expanding use of multimodal
imaging systems in oncology diagnosis, increasing demand for the early &
accurate diagnosis of cancer, and growing clinical evidence on the use of
multimodal imaging in the diagnosis of novel cancer types.
Regional Analysis: -
North
America accounted for the largest share of the multimodal imaging market in
2018
The multimodal imaging market is segmented into four
regional segments, namely, North America, Europe, Asia Pacific, Latin America,
and the Middle East & Africa. North America accounted for the largest share
of the multimodal imaging market owing to factors such as the increasing
availability of radiotracers, technological advancements in diagnostic imaging
modalities, high incidence/prevalence of diseases such as breast cancer and
colorectal cancer, large number of multimodal imaging procedures performed,
growing awareness about the benefits of early diagnosis of diseases, and the
rapid adoption of technologically advanced imaging systems.
Recent Developments:
·
In 2019, United Imaging Healthcare Co., Ltd. (China)
launched its uEXPLORER (full body PET/CT).
·
In 2018, GE Healthcare (US) launched its 800 series
SPECT/CT systems that include NM/CT 850, NM/CT 860, NM/CT 870 DR, and NM/CT 870
CZT.
·
In 2017, Siemens Healthineers (Germany) Launched its
Biograph Vision PET/CT system.
·
In 2016, Canon Inc. (Japan) completed the
acquisition of Toshiba Medical Systems Corporation, with the aim to include its
diagnostic imaging portfolio in its offering and expand its healthcare
business, globally.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=3358876
Top Key Players: -
The major players operating in the multimodal
imaging market are GE Healthcare (US), Siemens Healthineers (Germany),
Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd.
(China), Canon Medical Systems Corporation (Japan), Mediso Medical Imaging Kft
(Hungary), Neusoft Medical Systems Co., Ltd. (China), Spectrum Dynamics Medical
(Switzerland), Infraredx, Inc. (Japan), Topcon Corporation (Japan), Carl Zeiss
AG (Germany), and Heidelberg Engineering (Germany).
Conclusion
In conclusion,
the multimodal imaging market is a rapidly growing sector of the healthcare
industry due to the increasing demand for advanced medical imaging technologies
that can provide a more comprehensive and accurate view of the human body. With
the rising incidence of chronic diseases and growing investments by governments
and private organizations in healthcare infrastructure, the multimodal imaging
market is expected to continue to grow in the coming years.
No comments:
Post a Comment